Jarrod Johnson
Jarrod Johnson
Research Associate, McMaster University
Verified email at mcmaster.ca
Title
Cited by
Cited by
Year
Bacterial cell-wall recycling
JW Johnson, JF Fisher, S Mobashery
Annals of the New York Academy of Sciences 1277 (1), 54, 2013
2512013
How allosteric control of Staphylococcus aureus penicillin binding protein 2a enables methicillin resistance and physiological function
LH Otero, A Rojas-Altuve, LI Llarrull, C Carrasco-López, M Kumarasiri, ...
Proceedings of the National Academy of Sciences 110 (42), 16808-16813, 2013
2012013
Cyclobutanone analogues of β-lactams revisited: Insights into conformational requirements for inhibition of serine-and metallo-β-lactamases
JW Johnson, M Gretes, VJ Goodfellow, L Marrone, ML Heynen, ...
Journal of the American Chemical Society 132 (8), 2558-2560, 2010
532010
Cyclobutanone mimics of penicillins: Effects of substitution on conformation and hemiketal stability
JW Johnson, DP Evanoff, ME Savard, G Lange, TR Ramadhar, A Assoud, ...
The Journal of Organic Chemistry 73 (18), 6970-6982, 2008
422008
Evolving medicinal chemistry strategies in antibiotic discovery
AC Pawlowski, JW Johnson, GD Wright
Current opinion in biotechnology 42, 108-117, 2016
312016
Cyclobutanone mimics of intermediates in metallo‐β‐lactamase catalysis
MI Abboud, M Kosmopoulou, AP Krismanich, JW Johnson, P Hinchliffe, ...
Chemistry (Weinheim an der Bergstrasse, Germany) 24 (22), 5734, 2018
212018
A macrophage-based screen identifies antibacterial compounds selective for intracellular Salmonella Typhimurium
MJ Ellis, CN Tsai, JW Johnson, S French, W Elhenawy, S Porwollik, ...
Nature communications 10 (1), 1-14, 2019
182019
Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof
GI Dmitrienko, A Ghavami, VJ Goodfellow, JW Johnson, AP Krismanich, ...
US Patent App. 13/581,301, 2012
92012
Bate-lactamase inhibitors
GI Dmitrienko, JW Johnson, TR Ramadhar, T Viswanatha, S Viswanatha
US Patent App. 12/441,622, 2011
52011
Inhibitors of class B and class D β-lactamases
GI Dmitrienko, T Viswanatha, JW Johnson, TR Ramadhar
WO 114921, A1, 2009
42009
Natural products in antibiotic discovery
FR McSorley, JW Johnson, GD Wright
Antimicrobial Resistance in the 21st Century, 533-562, 2018
32018
Cyclobutanone Analogues of β-Lactam Antibiotics as Inhibitors of Serine-and Metallo-β-Lactamases
JW Johnson
University of Waterloo, Canada, 2011
22011
Chemical Screen for Vancomycin Antagonism Uncovers Probes of the Gram-Negative Outer Membrane
K Klobucar, JP Côté, S French, L Borrillo, ABY Guo, MH Serrano-Wu, ...
ACS Chemical Biology, 2021
12021
Hexafluoroisopropyl Sulfamate: A Useful Reagent for the Synthesis of Sulfamates and Sulfamides
MA Sguazzin, JW Johnson, J Magolan
Organic Letters 23 (9), 3373-3378, 2021
12021
Strategies for Circumventing Bacterial Resistance Mechanisms
JF Fisher, JW Johnson, S Mobashery
Handbook of Antimicrobial Resistance, 2014
2014
Toward a universal b-lactamase inhibitor: A collaborative, interdisciplinary, Canada-UK team effort
GI Dmitrienko, VJ Goodfellow, L Marrone, A Ghavami, AP Krismanich, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013
2013
CEPHALOSPORIN DERIVATIVES USEFUL AS-LACTAMASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF
GI Dmitrienko, A Ghavami, VJ Goodfellow, JW Johnson, AP Krismanich, ...
EP Patent 2,539,348, 2013
2013
Crystal Structures of Class A, B, and D β-Lactamases
JW Johnson, GI Dmitrienko
group 2, 1.85, 2007
2007
Cyclobutanone Analogues of-Lactams Revisited: Insights into Conformational Requirements for Inhibition of Serine-and Metallo--Lactamases
JW Johnson, M Gretes, VJ Goodfellow, L Marrone, ML Heynen, ...
The system can't perform the operation now. Try again later.
Articles 1–19